Skip to main content
Log in

The Chemistry of ATP in the Failing Heart The Fundamentals

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

There is now compelling evidence that the [ATP] in both failed human myocardium and animal models of severe heart failure is as much as 25% lower than in normal myocardium. We also know that the tissue contents of phosphocreatine and creatine and the capacity of the creatine kinase reaction (Vmax) are also lower in the dysfunctional/failing heart. These observations increase our understanding of two important aspects of cardiac energetics: the kinetics of ATP synthesis and the thermodynamics of ATP utilization, i.e., the chemical driving force for the ATP-consuming reactions, ΔG∼P. In this chapter, we will first review the fundamentals of the chemistry of ATP synthesis in the heart and then summarize what is known about the energetics of the failing heart from the viewpoints of the kinetics of ATP synthesis and the thermodynamics of ATP utilization. We present a new model of the energetics of the failing heart and suggest that the loss of creatine from the failing heart protects the heart from an even greater loss of ATP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Starling RC, Hammer DF, Altschuld RA. Human myocardial ATP content and in vivo contractile function. Molec Cell Biochem 1998;180:171–177.

    Google Scholar 

  2. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 1995;91:1824–1833.

    Google Scholar 

  3. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996;78:893–902.

    Google Scholar 

  4. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313:1050–1054.

    Google Scholar 

  5. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996;94:1894–1901.

    Google Scholar 

  6. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial Phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190–2196.

    Google Scholar 

  7. Ingwall JS. Energetics of the normal and failing human heart: Focus on the Cr kinase reaction. In: Altschuld RA, Haworth RA, eds (Bittar E, series ed). Advances in Organ Biology: Heart Metabolism and Failure. Greenwich, CT: Jai Press Inc., 1998:117–148.

    Google Scholar 

  8. Tian R, Nascimben L, Kaddurah-daouk R, Ingwall JS. Depletion of energy reserve via the Cr kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol 1996;28:755–765.

    Google Scholar 

  9. Bottomley PA, Weiss RG. Non-invasivemagnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998;351:714–718.

    Google Scholar 

  10. Ingwall JS, Nascimben L, Gwathmey JK. Heart failure: Is the pathology due to calcium overload or to mismatch in energy supply and demand? In: Gwathmey JK, Briggs GM, Allen PD, eds. Heart Failure: Basic Science and Clinical Aspects. New York: Marcel Dekker, Inc., 1993:667–699.

    Google Scholar 

  11. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem 1985;260:3512–3517.

    Google Scholar 

  12. Tian R, Christe ME, Spindler M, Hopkins JCA, Halow JM, Camacho A, Ingwall JS. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest 1997;99:745–751.

    Google Scholar 

  13. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of en-ergy metabolism of the heart during acute increase in heart work. J Biol Chem 1998;273:29530–29539.

    Google Scholar 

  14. Bak MI, Ingwall JS. Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5′-nucleotidase. J Clin Invest 1994;93:40–49.

    Google Scholar 

  15. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs. Circulation 1999;100:2113–2118.

    Google Scholar 

  16. Bak MI, Ingwall JS. Regulation of cardiac AMP-specific 5′-nucleotidase during ischemia mediates ATP resynthesis on re flow. Am J Physiol1998;274:C992–C1001.

    Google Scholar 

  17. Zimmer H-G, Trendelenburg C, Kammermeier H, Gerlach E. De novo synthesis of myocardial adenine nucleotides in the rat. Acceleration during recovery from oxygen deficiency. Circ Res 1973;32:635–642.

    Google Scholar 

  18. Morrison JF, Cleland WW. Isotype exchange studies of the mechanism of the reaction catalyzed by ATP: Creatine phosphotransferase. J Biol Chem 1966;241:673–683.

    Google Scholar 

  19. Shannon TR, Bers DM. Assessment of intra-SR free [Ca] and buffering in rat heart. Biophy J 1997;73:1524–1531.

    Google Scholar 

  20. Tian R, Ingwall JS. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol 1996;270(39): H1207–H1216.

    Google Scholar 

  21. Bashore TM, Magorien DJ, Letterio J, Shaffer O, Unverferth DV. Histologic and biochemical correlates of left ventricular chamber dynamics in man. J Am Coll Cardiol 1987;9:734–742.

    Google Scholar 

  22. Regitz V, Fleck E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1992;69:1574–1580.

    Google Scholar 

  23. Bittl JA, Ingwall JS. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. Circulation 1987;(75):I96–I101.

    Google Scholar 

  24. Ingwall JS. The hypertrophied myocardium accumulates the MB-creatine kinase isozyme. Eur Heart J 1984;5(F):129–139.

    Google Scholar 

  25. Ingwall JS, Atkinson DE, Clarke K, Fetters JK. Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J 1990;11(B): 108–115.

    Google Scholar 

  26. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993;87:VII-58–VII-62.

    Google Scholar 

  27. Conway MA, Allis J, Ouwerkerk R, Nhoka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine toATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991;338:973–976.

    Google Scholar 

  28. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. AmHeart J 1991;122:795–801.

    Google Scholar 

  29. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Madar H, Kromer EP, Riegger GAJ, Lackner K, Ertl G. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphatemetabolism in heart failure. Circulation 1992;86:1810–1818.

    Google Scholar 

  30. Jung W-I, Sieverding L, Breuer J, Hoess T, Widmaier S, Schmidt O, Bunse M, van Erckelens F, Apitz J, Lutz O, Dietze GJ. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536–2542.

    Google Scholar 

  31. Schultz A, Hess T, Wevers R, Mayatepak E, Bachert P, Marescau B, Knopp MV, De Deyn PP, Bremer HJ, Rating D. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism. J Pediatr 1997;131:626–631.

    Google Scholar 

  32. Seppet EK, Adoyann AJ, Kallikorm AP, Chernouska GB, Lyulina NV, Sharov VG, Sevenin VV, Popovich MI. Hormone regulation of cardiac energy metabolism. I. Creatine transport across cell membranes of euthyroid and hyperthyroid rat heart. Biochem Med 1985;34:267–279.

    Google Scholar 

  33. Fitch CD, Shields RP, Payne WF, Dacuse JM. Creatine metabolism in skeletal muscle. 3. Specificity of the creatine entry process. J Biol Chem 1968;243:2024–2027.

    Google Scholar 

  34. Loike JD, Zalutsky DL, Kaback E, Miranda AF, Silverstein SC. Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc Natl Acad Sci USA 1988;85:807–811.

    Google Scholar 

  35. Guimbal C, Kilimann MW. A Na(+)-dependent creatine transporter in rabbit brain,muscle, heart, and kidney. cDNA cloning and functional expression. J Biol Chem 1993;268: 8418–8421.

    Google Scholar 

  36. McAuliffe JJ, Perry SB, Brooks EE, Ingwall JS. Kinetics of the creatine kinase reaction in neonatal rabbit heart: an empirical analysis of the rate equation. Biochemistry 1991;30:2585–2593.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ingwall, J.S., Shen, W. The Chemistry of ATP in the Failing Heart The Fundamentals. Heart Fail Rev 4, 221–228 (1999). https://doi.org/10.1023/A:1009857906567

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009857906567

Navigation